Research from earlier this week is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people's ...

A new study has found that drugs like Ozempic, which were originally designed for people with type 2 diabetes before gaining ...

A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half. What doesn’t it ...

The analysis named the 25 U.S. life science startups most likely to go public, including a Denver-based diabetes treatment ...

STAT reporters discuss investors' interest in autoimmune disease, GLP-1 supply issues, and big moments from #STATSummit.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

First, bariatric surgery added two quality-adjusted life years and saved patients about $9,000 more each year compared to GLP-1s. Second, combining surgery and GLP-1s led to more benefits, with ...

In a huge new study, researchers have found evidence that drugs like Ozempic can help with alcohol and opioid addiction.

Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...

U.S. Public Interest Research Group, Service Employees International Union (SEIU) and others expressed concerns in a letter ...

Those who took Ozempic or a similar drug had a 40% lower chance of overdosing on opioids and a 50% lower chance of getting ...